Dudediligence.

PTC Therapeutics, Inc

PTCTNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$196.8MSep ’24$213.2MDec ’24$1.18BMar ’25$178.9MJun ’25$211.0MSep ’25$164.7MDec ’25$272.6MMar ’26$360.5MJun ’26
Net income, by quarter
−$106.7MSep ’24−$65.9MDec ’24$866.6MMar ’25−$64.8MJun ’25$15.9MSep ’25−$134.6MDec ’25−$2.8MMar ’26$83.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$538.6M$698.8M$937.8M$806.8M$1.73B
Operating income−$374.4M−$447.4M−$439.5M−$302.6M$866.9M
Net income−$523.9M−$559.0M−$626.6M−$363.3M$683.0M
Operating cash flow−$251.3M−$356.7M−$158.4M−$107.7M$711.2M
Free cash flow−$279.5M−$388.7M−$186.9M−$114.2M$702.3M
Cash$189.7M$279.8M$594.0M$779.7M$984.6M
Debt$431.4M$571.7M$284.2M$285.4M$286.6M
Shares outstanding70.8M73.1M75.7M77.7M81.5M